Mandate

Vinge advises Industrifonden and SEB in connection with Clavister investment

April 16, 2012

Vinge has advised Industrifonden and SEB Venture Capital in connection with their approximately SEK 40 million investment in the security company Clavister AB. The company, which has its registered office in Örnsköldsvik, offers advanced security products focusing on the telecoms industry, cloud computing environments and large corporate customers. The capital will be used for the company’s future international expansion.

SEB Venture Capital was founded in 1995 and is part of the SEB group. With a capital base of SEK 2 500 million, the company has thus far made 36 investments in technology and healthcare enterprises and performed 36 exits. Read more about SEB Venture Capital by visiting www.seb.se/venturecapital

Industrifonden has assets worth SEK 3.8 billion and investments in 89 companies within the technology, cleantech, life science and industrial sectors. This is Industrfonden’s seventh new investment for the financial year comprising 1 July 2011 to 30 June 2012. Read more about Industrifonden by visiting www.industrifonden.se

Vinge’e team consisted of partner Johan Larsson together with associates Philip Watson and Martin Hall.     

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026